BMSSC
ITCI

B. Metzler seel. Sohn & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,305
Closed -$1.53M – 770
2024
Q4 		$1.53M Sell
18,305
-14,986
-45% -$1.23M 0.02% 441
2024
Q3 		$2.44M Buy
33,291
+2,950
+10% +$222K 0.02% 342
2024
Q2 		$2.08M Hold
30,341
– – 0.02% 373
2024
Q1 		$2.1M Buy
30,341
+4,334
+17% +$298K 0.02% 377
2023
Q4 		$1.86M Buy
26,007
+374
+1% +$21.5K 0.02% 376
2023
Q3 		$1.34M Sell
25,633
-22,389
-47% -$1.3M 0.02% 403
2023
Q2 		$3.04M Buy
48,022
+20,412
+74% +$1.27M 0.04% 293
2023
Q1 		$1.5M Sell
27,610
-3,014
-10% -$146K 0.02% 369
2022
Q4 		$1.62M Buy
30,624
+2,137
+8% +$107K 0.03% 347
2022
Q3 		$1.33M Buy
28,487
+478
+2% +$25K 0.02% 375
2022
Q2 		$1.6M Sell
28,009
-7,422
-21% -$421K 0.03% 345
2022
Q1 		$2.17M Buy
35,431
+3,600
+11% +$187K 0.03% 326
2021
Q4 		$1.66M Sell
31,831
-10,629
-25% -$446K 0.02% 348
2021
Q3 		$1.58M Buy
42,460
+22,706
+115% +$789K 0.02% 353
2021
Q2 		$806K Sell
19,754
-2,391
-11% -$88.4K 0.01% 479
2021
Q1 		$751K Buy
22,145
+522
+2% +$18.1K 0.01% 475
2020
Q4 		$697K Buy
+21,623
New +$568K 0.01% 463

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ITCI Position: Q1 2025 in Review

B. Metzler seel. Sohn & Co sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 18,305 shares — an estimated $1.53M sold.

B. Metzler seel. Sohn & Co first reported a position in ITCI in Q4 2020 and held it in 17 quarters. The position peaked at $3.04M in Q2 2023. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • B. Metzler seel. Sohn & Co reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 18,305 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $1.53M.
  • B. Metzler seel. Sohn & Co first reported a position in Intra-Cellular Therapies Inc. in Q4 2020 and held it in 17 quarters.
  • B. Metzler seel. Sohn & Co's Intra-Cellular Therapies Inc. position peaked at $3.04M in Q2 2023.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2025, filed 14 May 2025.